Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,821 | 10,710 | 4,810 | 795 | 1,798 |
| TOTAL | $8,358 | $10,985 | $6,065 | $1,360 | $2,305 |
| Non-Current Assets | |||||
| PPE Net | 36 | 41 | N/A | N/A | N/A |
| Other Non-Current Assets | 30 | 31 | 32 | 33 | 34 |
| TOTAL | $66 | $72 | $32 | $33 | $34 |
| Total Assets | $8,423 | $11,057 | $6,097 | $1,393 | $2,339 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,076 | 1,080 | 1,104 | 1,482 | 1,471 |
| Accrued Expenses | 245 | 862 | 745 | 741 | 695 |
| TOTAL | $4,546 | $5,168 | $1,849 | $2,223 | $2,278 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,226 | 3,226 | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,546 | $5,168 | $1,849 | $2,223 | $2,278 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 532 | 532 | 488 | 42 | 12 |
| Retained earnings | -96,667 | -94,442 | -85,464 | -84,591 | -83,633 |
| TOTAL | $3,877 | $5,889 | $4,248 | $-830 | $62 |
| Total Liabilities And Equity | $8,423 | $11,057 | $6,097 | $1,393 | $2,339 |